NO20076448L - Novel piperidine carboxylic acid amide derivatives - Google Patents
Novel piperidine carboxylic acid amide derivativesInfo
- Publication number
- NO20076448L NO20076448L NO20076448A NO20076448A NO20076448L NO 20076448 L NO20076448 L NO 20076448L NO 20076448 A NO20076448 A NO 20076448A NO 20076448 A NO20076448 A NO 20076448A NO 20076448 L NO20076448 L NO 20076448L
- Authority
- NO
- Norway
- Prior art keywords
- carboxylic acid
- acid amide
- amide derivatives
- piperidine carboxylic
- novel piperidine
- Prior art date
Links
- JSPCTNUQYWIIOT-UHFFFAOYSA-N piperidine-1-carboxamide Chemical class NC(=O)N1CCCCC1 JSPCTNUQYWIIOT-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002461 renin inhibitor Substances 0.000 abstract 1
- 229940086526 renin-inhibitors Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2005005732 | 2005-05-27 | ||
| IB2006050134 | 2006-01-13 | ||
| PCT/IB2006/051641 WO2006129237A2 (en) | 2005-05-27 | 2006-05-23 | Novel piperidine carboxylic acid amide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20076448L true NO20076448L (no) | 2008-01-29 |
Family
ID=37441531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20076448A NO20076448L (no) | 2005-05-27 | 2007-12-17 | Novel piperidine carboxylic acid amide derivatives |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7799805B2 (es) |
| EP (1) | EP1893578A2 (es) |
| JP (1) | JP4297972B2 (es) |
| KR (1) | KR100963455B1 (es) |
| AR (1) | AR054766A1 (es) |
| AU (1) | AU2006253805A1 (es) |
| BR (1) | BRPI0609890A2 (es) |
| CA (1) | CA2608212A1 (es) |
| EC (1) | ECSP078016A (es) |
| GE (1) | GEP20115206B (es) |
| IL (1) | IL187631A0 (es) |
| MA (1) | MA29554B1 (es) |
| MX (1) | MX2007014722A (es) |
| MY (1) | MY146404A (es) |
| NI (1) | NI200700292A (es) |
| NO (1) | NO20076448L (es) |
| NZ (1) | NZ564689A (es) |
| RU (1) | RU2410374C2 (es) |
| TN (1) | TNSN07435A1 (es) |
| TW (1) | TWI349006B (es) |
| WO (1) | WO2006129237A2 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE462703T1 (de) * | 2004-08-25 | 2010-04-15 | Actelion Pharmaceuticals Ltd | Bicyclononen-derivate als renin-inhibitoren |
| NZ570828A (en) | 2006-02-02 | 2011-07-29 | Actelion Pharmaceuticals Ltd | Secondary amines as renin inhibitors |
| CN101395149A (zh) * | 2006-03-08 | 2009-03-25 | 埃科特莱茵药品有限公司 | 新颖胺类 |
| US8129538B1 (en) | 2007-03-28 | 2012-03-06 | Takeda Pharmaceutical Company Limited | Renin inhibitors |
| AU2008253519A1 (en) * | 2007-05-24 | 2008-11-27 | Merck Frosst Canada Ltd | Novel case of renin inhibitors |
| TWI452044B (zh) * | 2007-06-15 | 2014-09-11 | Mitsubishi Tanabe Pharma Corp | 嗎啉衍生物 |
| AU2008288648A1 (en) | 2007-08-20 | 2009-02-26 | Merck Frosst Canada Ltd. | Renin inhibitors |
| KR101403311B1 (ko) * | 2008-05-05 | 2014-06-05 | 액테리온 파마슈티칼 리미티드 | 레닌 억제제로서의 3,4-치환된 피페리딘 유도체 |
| WO2010011584A2 (en) * | 2008-07-25 | 2010-01-28 | Merck & Co., Inc. | Process for making a renin inhibitor |
| EP2376473A4 (en) * | 2008-12-10 | 2012-05-02 | Merck Canada Inc | 3,4-SUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS |
| RS53827B1 (sr) | 2009-11-02 | 2015-06-30 | Pfizer Inc. | Derivati dioksa-biciklo[3.2.1]oktan-2,3,4-triola |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380758A (en) | 1991-03-29 | 1995-01-10 | Brigham And Women's Hospital | S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| US5175179A (en) * | 1991-09-25 | 1992-12-29 | Pfizer Inc. | Method for treating hypertension |
| US5703073A (en) | 1995-04-19 | 1997-12-30 | Nitromed, Inc. | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| TR199800409T1 (xx) | 1995-09-07 | 1998-05-21 | F.Hoffmann-La Roche Ag | Kalp ve b�brek yetersizli�inin tedavii�in yeni 4-(oksialkoksifenil)-3-oksi-piperidinler |
| US5994294A (en) | 1996-02-02 | 1999-11-30 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| US6677148B1 (en) * | 1996-04-19 | 2004-01-13 | Mycogen Corporation | Pesticidal proteins |
| WO1998019672A1 (en) | 1996-11-01 | 1998-05-14 | Nitromed Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| IT1295694B1 (it) | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
| IT1292426B1 (it) | 1997-06-27 | 1999-02-08 | Nicox Sa | Sali nitrati di ace-inibitori |
| US6197959B1 (en) | 1999-04-27 | 2001-03-06 | Hoffmann-La Roche Inc. | Piperidine derivatives |
| US6376672B1 (en) | 1999-04-27 | 2002-04-23 | Hoffmann-La Roche Inc. | Naphthalenylmethoxypiperidines as renin inhibitors |
| EP1389194A2 (en) | 2001-04-27 | 2004-02-18 | Vertex Pharmaceuticals Incorporated | Inhibitors of bace |
| CA2483241C (en) | 2002-04-29 | 2011-05-31 | Actelion Pharmaceuticals Ltd | Novel diazabicyclononene derivatives |
| RU2005102002A (ru) * | 2002-06-27 | 2005-09-20 | Актелион Фармасьютиклз Лтд. (Ch) | Новые производные тетрагидропиридина |
| US20040204455A1 (en) * | 2003-04-10 | 2004-10-14 | Cody Wayne Livingston | Piperidine derivative rennin inhibitors |
| TW200900399A (en) | 2003-10-01 | 2009-01-01 | Speedel Experimenta Ag | Organic compounds |
| CN1906163A (zh) | 2003-11-26 | 2007-01-31 | 诺瓦提斯公司 | 作为肾素抑制剂的4－苯基哌啶衍生物 |
| AR053406A1 (es) | 2004-07-09 | 2007-05-09 | Speedel Experimenta Ag | Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas |
| ATE462703T1 (de) * | 2004-08-25 | 2010-04-15 | Actelion Pharmaceuticals Ltd | Bicyclononen-derivate als renin-inhibitoren |
| GB0428526D0 (en) * | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
| KR100938364B1 (ko) * | 2005-01-28 | 2010-01-22 | 액테리온 파마슈티칼 리미티드 | 고혈압 치료를 위한, 레닌의 억제제로서의 7-｛4-[2-(2,6-디클로로-4-메틸페녹시)에톡시]페닐｝-3,9-디아자비시클로[3.3.1]논-6-엔-6-카르복실산 시클로프로필-(2,3-디메틸벤질)아미드 |
| TW200716622A (en) | 2005-03-31 | 2007-05-01 | Speedel Experimenta Ag | Substituted piperidines |
| TW200722424A (en) | 2005-03-31 | 2007-06-16 | Speedel Experimenta Ag | Substituted piperidines |
| BRPI0609534A2 (pt) | 2005-03-31 | 2010-04-13 | Speedel Experimenta Ag | piperidinas 3,4,5-substituìdas |
| GB0510810D0 (en) | 2005-05-26 | 2005-06-29 | Novartis Ag | Organic compounds |
| NZ570828A (en) * | 2006-02-02 | 2011-07-29 | Actelion Pharmaceuticals Ltd | Secondary amines as renin inhibitors |
| CN101395149A (zh) * | 2006-03-08 | 2009-03-25 | 埃科特莱茵药品有限公司 | 新颖胺类 |
-
2006
- 2006-05-23 GE GEAP200610460A patent/GEP20115206B/en unknown
- 2006-05-23 CA CA002608212A patent/CA2608212A1/en not_active Abandoned
- 2006-05-23 JP JP2008512998A patent/JP4297972B2/ja not_active Expired - Fee Related
- 2006-05-23 MX MX2007014722A patent/MX2007014722A/es active IP Right Grant
- 2006-05-23 RU RU2007149410/04A patent/RU2410374C2/ru not_active IP Right Cessation
- 2006-05-23 AU AU2006253805A patent/AU2006253805A1/en not_active Abandoned
- 2006-05-23 EP EP06765703A patent/EP1893578A2/en not_active Withdrawn
- 2006-05-23 WO PCT/IB2006/051641 patent/WO2006129237A2/en not_active Ceased
- 2006-05-23 US US11/915,594 patent/US7799805B2/en not_active Expired - Fee Related
- 2006-05-23 KR KR1020077030602A patent/KR100963455B1/ko not_active Expired - Fee Related
- 2006-05-23 BR BRPI0609890-8A patent/BRPI0609890A2/pt not_active IP Right Cessation
- 2006-05-23 NZ NZ564689A patent/NZ564689A/en not_active IP Right Cessation
- 2006-05-25 MY MYPI20062433A patent/MY146404A/en unknown
- 2006-05-26 TW TW095118812A patent/TWI349006B/zh not_active IP Right Cessation
- 2006-05-26 AR ARP060102197A patent/AR054766A1/es not_active Application Discontinuation
-
2007
- 2007-11-15 NI NI200700292A patent/NI200700292A/es unknown
- 2007-11-23 TN TNP2007000435A patent/TNSN07435A1/en unknown
- 2007-11-26 IL IL187631A patent/IL187631A0/en unknown
- 2007-12-14 EC EC2007008016A patent/ECSP078016A/es unknown
- 2007-12-17 NO NO20076448A patent/NO20076448L/no not_active Application Discontinuation
- 2007-12-20 MA MA30489A patent/MA29554B1/fr unknown
-
2010
- 2010-08-12 US US12/855,016 patent/US20100324052A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006129237A3 (en) | 2007-03-22 |
| US20100324052A1 (en) | 2010-12-23 |
| AU2006253805A1 (en) | 2006-12-07 |
| TW200718695A (en) | 2007-05-16 |
| BRPI0609890A2 (pt) | 2010-05-04 |
| KR100963455B1 (ko) | 2010-06-18 |
| NI200700292A (es) | 2008-06-17 |
| MA29554B1 (fr) | 2008-06-02 |
| EP1893578A2 (en) | 2008-03-05 |
| MX2007014722A (es) | 2008-02-15 |
| US20080214598A1 (en) | 2008-09-04 |
| WO2006129237A2 (en) | 2006-12-07 |
| AR054766A1 (es) | 2007-07-18 |
| KR20080014088A (ko) | 2008-02-13 |
| CA2608212A1 (en) | 2006-12-07 |
| MY146404A (en) | 2012-08-15 |
| GEP20115206B (en) | 2011-04-26 |
| ECSP078016A (es) | 2008-02-20 |
| IL187631A0 (en) | 2008-03-20 |
| NZ564689A (en) | 2011-02-25 |
| TNSN07435A1 (en) | 2009-03-17 |
| RU2007149410A (ru) | 2009-07-10 |
| JP2008542257A (ja) | 2008-11-27 |
| JP4297972B2 (ja) | 2009-07-15 |
| RU2410374C2 (ru) | 2011-01-27 |
| TWI349006B (en) | 2011-09-21 |
| US7799805B2 (en) | 2010-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20076448L (no) | Novel piperidine carboxylic acid amide derivatives | |
| NO20092723L (no) | Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer | |
| NO20084186L (no) | Nye aminer | |
| NO20085212L (no) | Nye pyridinanaloger | |
| NO20090628L (no) | Pyridizinon derivativater | |
| NO20083738L (no) | Sekundaere aminer som renininhibitorer | |
| NO20071617L (no) | Indozolonderivater som 11B-HSD1-inhibitorer | |
| NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
| NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
| NO20083836L (no) | N-hydroksyakrylamidforbindelser | |
| NO20070445L (no) | Pyrimidinderivater. | |
| NO20050290L (no) | Nye tetrahydropyridin-derivater som renin-inhibitorer | |
| NO20074258L (no) | Pyridin-2-karboksamidderivater som MGLUR5 antagonister | |
| EA200901124A1 (ru) | Соединения формулы (i) в качестве ингибиторов серинпротеазы | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| WO2004113297A3 (en) | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
| NO20084055L (no) | Nye primaere aminer | |
| NO20071805L (no) | Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere. | |
| NO20083201L (no) | Nye fenantridinderivater som bradykininantagonister | |
| NO20055624L (no) | Tropanderivater og deres anvendelse som Ace-inhibitorer | |
| NO20064351L (no) | Caspaseinhibitorer og anvendelser derav | |
| WO2008036316A3 (en) | Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease | |
| NO20080839L (no) | Isotopsubstituerte protonpumpeinhibitorer | |
| ATE462703T1 (de) | Bicyclononen-derivate als renin-inhibitoren | |
| TW200628468A (en) | Bicyclononene derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |